305 related articles for article (PubMed ID: 17417082)
1. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients.
Okamoto G; Sakamoto T; Kimura M; Ukishima Y; Sonoda A; Mori N; Kato Y; Maeda T; Kagawa Y
Clin Biochem; 2007 Apr; 40(7):485-90. PubMed ID: 17336280
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
5. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods.
White C; Akbari A; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
J Am Soc Nephrol; 2005 Dec; 16(12):3763-70. PubMed ID: 16236805
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H
J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409
[TBL] [Abstract][Full Text] [Related]
7. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C as an endogenous marker of renal function in the elderly.
Hojs R; Bevc S; Antolinc B; Gorenjak M; Puklavec L
Int J Clin Pharmacol Res; 2004; 24(2-3):49-54. PubMed ID: 15689051
[TBL] [Abstract][Full Text] [Related]
9. Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?
DeCarolis DD; Thorson JG; Marraffa RA; Clairmont MA; Kuskowski MA
Ther Drug Monit; 2014 Oct; 36(5):632-9. PubMed ID: 25222855
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?
Maillard N; Mariat C; Bonneau C; Mehdi M; Thibaudin L; Laporte S; Alamartine E; Chamson A; Berthoux F
Transplantation; 2008 Jun; 85(12):1855-8. PubMed ID: 18580481
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of equations based on serum cystatin C concentration in the study of renal function].
Chiurchiu C; Garces N; Garay G; Holtz R; Douthat W; de Arteaga J; Capra R; Massari PU
Medicina (B Aires); 2007; 67(2):136-42. PubMed ID: 17593597
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C as a reliable marker of changes in glomerular filtration rate in children with urinary tract malformations.
Corrao AM; Lisi G; Di Pasqua G; Guizzardi M; Marino N; Ballone E; Chiesa PL
J Urol; 2006 Jan; 175(1):303-9. PubMed ID: 16406933
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C is a better marker of topotecan clearance than serum creatinine.
Hoppe A; Séronie-Vivien S; Thomas F; Delord JP; Malard L; Canal P; Chatelut E
Clin Cancer Res; 2005 Apr; 11(8):3038-44. PubMed ID: 15837759
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
Suzuki A; Imanishi Y; Nakano S; Niwa T; Ohmori T; Shirai K; Yoshida S; Furuta N; Takemura M; Ito H; Ieiri I; Seishima M; Ogura S; Itoh Y
J Pharm Pharmacol; 2010 Jul; 62(7):901-7. PubMed ID: 20636878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
